Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
- Status
- TERMINATED
- Phase
- PHASE1
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE1
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)
- Status
- COMPLETED
- Phase
- NA
Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- NA
Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Autologous Transplant in HIV Patients (BMT CTN 0803)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm
- Status
- COMPLETED
- Phase
- PHASE2
Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- N/A
ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML)
- Status
- WITHDRAWN
- Phase
- PHASE3
Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1